Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

NCT01118819 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped This study was terminated. An IT injection study of C. novyi-NT in patients with treatment refractory solid tumor malignancies may be viewed at NCT01924689.

Conditions

Interventions

Sponsor

BioMed Valley Discoveries, Inc